Header Logo

Connection

SEIJI KITAGAWA to Adalimumab

Back to Details
This is a "connection" page, showing publications SEIJI KITAGAWA has written about Adalimumab.
SEIJI KITAGAWA
Connection Strength
0.051
Adalimumab
  1. Infliximab Can Be Effective in Pediatric Patients with Ulcerative Colitis and Primary Failure of Adalimumab. Ann Clin Lab Sci. 2022 Sep; 52(5):796-801.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.